LLY

1,021.53

+0.15%↑

JNJ

198.84

+0.64%↑

ABBV

234.93

+0.34%↑

UNH

310.95

-4.31%↓

AZN

89.04

-0.31%↓

LLY

1,021.53

+0.15%↑

JNJ

198.84

+0.64%↑

ABBV

234.93

+0.34%↑

UNH

310.95

-4.31%↓

AZN

89.04

-0.31%↓

LLY

1,021.53

+0.15%↑

JNJ

198.84

+0.64%↑

ABBV

234.93

+0.34%↑

UNH

310.95

-4.31%↓

AZN

89.04

-0.31%↓

LLY

1,021.53

+0.15%↑

JNJ

198.84

+0.64%↑

ABBV

234.93

+0.34%↑

UNH

310.95

-4.31%↓

AZN

89.04

-0.31%↓

LLY

1,021.53

+0.15%↑

JNJ

198.84

+0.64%↑

ABBV

234.93

+0.34%↑

UNH

310.95

-4.31%↓

AZN

89.04

-0.31%↓

Search

Merit Medical Systems Inc

Abrir

SetorSaúde

85.22 -0.32

Visão Geral

Variação de preço das ações

24h

Atual

Mín

85.16

Máximo

87.37

Indicadores-chave

By Trading Economics

Rendimento

-4.8M

28M

Vendas

1.7M

384M

P/E

Médio do Setor

45.297

105.69

EPS

0.92

Margem de lucro

7.225

Funcionários

7,400

EBITDA

-41M

43M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+17.23% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

337M

5.2B

Abertura anterior

85.54

Fecho anterior

85.22

Sentimento de Notícias

By Acuity

52%

48%

305 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Merit Medical Systems Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de nov. de 2025, 18:59 UTC

Grandes Movimentos do Mercado

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

17 de nov. de 2025, 23:40 UTC

Conversa de Mercado

Gold Consolidates Amid Mixed Signals -- Market Talk

17 de nov. de 2025, 23:34 UTC

Conversa de Mercado

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

17 de nov. de 2025, 22:58 UTC

Conversa de Mercado

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

17 de nov. de 2025, 22:46 UTC

Conversa de Mercado

Risk Assets Set to Have a Strong 2026 -- Market Talk

17 de nov. de 2025, 22:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

17 de nov. de 2025, 22:02 UTC

Ganhos

Trip.com Group 3Q Rev $2.6B >TCOM

17 de nov. de 2025, 22:02 UTC

Ganhos

Trip.com Group 3Q Adj EPS $3.87 >TCOM

17 de nov. de 2025, 22:02 UTC

Ganhos

Trip.com Group 3Q EPS $4.02 >TCOM

17 de nov. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de nov. de 2025, 21:40 UTC

Ganhos

James Hardie Industries 2Q Adj EPS 26c >JHX

17 de nov. de 2025, 21:40 UTC

Ganhos

James Hardie Industries 2Q Loss/Shr 10c >JHX

17 de nov. de 2025, 21:39 UTC

Ganhos

James Hardie Industries 2Q Sales $1.29B >JHX

17 de nov. de 2025, 21:38 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 de nov. de 2025, 21:38 UTC

Ganhos

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

17 de nov. de 2025, 21:10 UTC

Ganhos

XP Inc. 3Q EPS BRL2.47 >XP

17 de nov. de 2025, 21:10 UTC

Ganhos

XP Inc. 3Q Rev BRL4.67B >XP

17 de nov. de 2025, 20:20 UTC

Conversa de Mercado

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

17 de nov. de 2025, 20:12 UTC

Conversa de Mercado

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

17 de nov. de 2025, 20:12 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de nov. de 2025, 20:09 UTC

Conversa de Mercado

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

17 de nov. de 2025, 19:29 UTC

Conversa de Mercado

Gold Slide Continues to Start Week -- Market Talk

17 de nov. de 2025, 19:16 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 de nov. de 2025, 18:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

17 de nov. de 2025, 16:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

17 de nov. de 2025, 16:16 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 de nov. de 2025, 16:15 UTC

Ganhos

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

17 de nov. de 2025, 15:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

17 de nov. de 2025, 15:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

17 de nov. de 2025, 15:19 UTC

Conversa de Mercado

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Comparação entre Pares

Variação de preço

Merit Medical Systems Inc Previsão

Preço-alvo

By TipRanks

17.23% parte superior

Previsão para 12 meses

Média 100.57 USD  17.23%

Máximo 109 USD

Mínimo 90 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Merit Medical Systems Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

6

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

95.585 / 96.35Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

305 / 374 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Merit Medical Systems Inc

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
help-icon Live chat